Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.79 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.79 |
| ▸ | MEN1 | O00255 | 5/20 | 0.79 |
| ▸ | THRB | P10828 | 1/20 | 0.79 |
| ▸ | LMNA | P02545 | 8/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.77 |
| ▸ | ESR1 | P03372 | 6/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.77 |
| ▸ | ADORA3 | P0DMS8 | 5/20 | 0.77 |
| ▸ | TP53 | P04637 | 4/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.77 |
| ▸ | PGR | P06401 | 3/20 | 0.77 |
| ▸ | AR | P10275 | 3/20 | 0.77 |
| ▸ | ATM | Q13315 | 3/20 | 0.77 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.77 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.77 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.77 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.77 |
| ▸ | POLB | P06746 | 1/20 | 0.77 |
| ▸ | USP2 | O75604 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32662764 | 0.99 | MAPT (0.77) | MAPTKMT2AMEN1THRBLMNA | |
| SCHEMBL32662630 | 0.99 | MAPT (0.77) | MAPTKMT2AMEN1THRBLMNA | |
| SCHEMBL31648759 | 0.99 | MAPT (0.77) | MAPTKMT2AMEN1THRBLMNA | |
| SCHEMBL8506439 | 0.99 | MAPT (0.77) | MAPTKMT2AMEN1THRBLMNA | |
| SCHEMBL4265262 | 0.99 | MAPT (0.77) | MAPTKMT2AMEN1THRBLMNA | |
| SCHEMBL146888 | 0.97 | LMNA (0.82) | MAPTKMT2AMEN1THRBLMNA | |
| SCHEMBL32661972 | 0.94 | MAPT (0.71) | MAPTKMT2AMEN1THRBLMNA | |
| SCHEMBL9404737 | 0.94 | MAPT (0.83) | MAPTKMT2AMEN1THRBLMNA | |
| SCHEMBL9404738 | 0.92 | LMNA (0.79) | MAPTKMT2AMEN1THRBLMNA | |
| Estradiol Dipropionate SCHEMBL11698942 | 0.90 | MAPT (0.82) | MAPTKMT2AMEN1THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0744944-B1 | SEXUAL STEROID-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEMS | SCHERING AG (DE) | 1999-11-03 | — | — | EP | disclosed |
| US-5904931-A | MATRIX LAYER WITH SEX STEROIDS, ADHESIVE AND KETODESOGESTREL | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-05-18 | — | — | US | disclosed |
| US-5858394-A | Agent for transdermal administration that contains gestodene esters | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-01-12 | — | — | US | disclosed |
| US-5798338-A | STEROID/BETA-CYCLODEXTRIN CLATHRATE; OXIDATION RESISTANCE | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-08-25 | — | — | US | disclosed |
| US-5788984-A | UNIFORM DRUG DELIVERY | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-08-04 | — | — | US | disclosed |
| EP-0848620-A1 | AGENT, FOR TRANSDERMAL APPLICATION, CONTAINING ESTERS OF 3-KETODESOGESTREL | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-06-24 | — | — | EP | disclosed |
| EP-0655916-B1 | TRANSDERMAL APPLICATION AGENT CONTAINING 3-KETO-DESOGESTREL | SCHERING AG (DE) | 1998-02-04 | — | — | EP | disclosed |
| EP-0771217-A1 | SOLID DRUG FORMS CONTAINING CLATHRATES OF STEROID SEX HORMONES | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-05-07 | — | — | EP | disclosed |
| WO-1997003709-A1 | AGENT, FOR TRANSDERMAL APPLICATION, CONTAINING ESTERS OF 3-KETODESOGESTREL | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-02-06 | — | — | WO | disclosed |
| EP-0744943-A1 | DESOGESTREL-CONTAINING TRANSDERMAL APPLICATION AGENT | SCHERING AKTIENGESELLSCHAFT (DE) | 1996-12-04 | — | — | EP | disclosed |
| EP-0370220-B1 | Gestode composition for transdermal application | SCHERING AG (DE) | 1996-01-10 | — | — | EP | disclosed |
| WO-1995022322-A1 | SEXUAL STEROID-CONTAINING TRANSDERMAL THERAPEUTIC SYSTEMS | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-08-24 | — | — | WO | disclosed |
| WO-1995022321-A1 | DESOGESTREL-CONTAINING TRANSDERMAL APPLICATION AGENT | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-08-24 | — | — | WO | disclosed |
| EP-0655916-A1 | TRANSDERMAL APPLICATION AGENT CONTAINING 3-KETO-DESOGESTREL | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-06-07 | — | — | EP | disclosed |
| WO-1995005827-A1 | AGENT FOR TRANSDERMAL APPLICATION CONTAINING GESTODEN ESTERS | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-03-02 | — | — | WO | disclosed |
| WO-1994004157-A1 | TRANSDERMAL APPLICATION AGENT CONTAINING 3-KETO-DESOGESTREL | SCHERING AKTIENGESELLSCHAFT (DE) | 1994-03-03 | — | — | WO | disclosed |
| EP-0573133-A1 | Means for transdermal application of Gestoden | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-12-08 | — | — | EP | disclosed |
| EP-0394429-A1 | PREPARATION FOR TRANSDERMAL APPLICATION CONTAINING GESTODENE. | SCHERING AG (DE) | 1990-10-31 | — | — | EP | disclosed |
| EP-0370220-A1 | Gestode composition for transdermal application | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-05-30 | — | — | EP | disclosed |
| WO-1990004397-A1 | PREPARATION FOR TRANSDERMAL APPLICATION CONTAINING GESTODENE | SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) | 1990-05-03 | — | — | WO | disclosed |